IN2012DN03632A - - Google Patents

Download PDF

Info

Publication number
IN2012DN03632A
IN2012DN03632A IN3632DEN2012A IN2012DN03632A IN 2012DN03632 A IN2012DN03632 A IN 2012DN03632A IN 3632DEN2012 A IN3632DEN2012 A IN 3632DEN2012A IN 2012DN03632 A IN2012DN03632 A IN 2012DN03632A
Authority
IN
India
Prior art keywords
weight
amount
fos
present
inulin
Prior art date
Application number
Other languages
English (en)
Inventor
Zamzam Fariba Roughead
Jalil Benyacoub
Claudia Roessle
Jennifer Rae Mager
Julie Ann Swanson
Norman Alan Greenberg
Douglas Richard Bolster
Rodenas Clara Lucia Garcia
Florence Rochat
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43567734&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN03632(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN03632A publication Critical patent/IN2012DN03632A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/244Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/25Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
IN3632DEN2012 2009-11-12 2010-11-11 IN2012DN03632A (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US26049509P 2009-11-12 2009-11-12
US26443009P 2009-11-25 2009-11-25
US39480510P 2010-10-20 2010-10-20
PCT/US2010/056321 WO2011060123A1 (fr) 2009-11-12 2010-11-11 Composition nutritionnelle permettant de favoriser l'équilibre de microbiotes digestifs et la santé

Publications (1)

Publication Number Publication Date
IN2012DN03632A true IN2012DN03632A (fr) 2015-06-26

Family

ID=43567734

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3632DEN2012 IN2012DN03632A (fr) 2009-11-12 2010-11-11

Country Status (14)

Country Link
US (2) US9192179B2 (fr)
EP (1) EP2498626B1 (fr)
JP (2) JP6006117B2 (fr)
CN (2) CN104206946A (fr)
AU (1) AU2010319490B2 (fr)
BR (1) BR112012011294B1 (fr)
CA (1) CA2777941C (fr)
DK (1) DK2498626T3 (fr)
ES (1) ES2545597T3 (fr)
HK (1) HK1172516A1 (fr)
IN (1) IN2012DN03632A (fr)
MX (1) MX336032B (fr)
RU (1) RU2012123959A (fr)
WO (1) WO2011060123A1 (fr)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104206946A (zh) * 2009-11-12 2014-12-17 雀巢产品技术援助有限公司 用于促进肠微生物群平衡和健康的营养组合物
CN108741083A (zh) * 2010-12-31 2018-11-06 雅培制药有限公司 促进有益细菌生长的中性人乳寡糖
WO2012177556A2 (fr) 2011-06-20 2012-12-27 H.J. Heinz Company Méthodes et compositions probiotiques
WO2012175639A1 (fr) * 2011-06-22 2012-12-27 Universite De Rouen Protéines arabinogalactanes pour l'utilisation en tant qu'agent antiparasitaire
FI126711B (fi) * 2011-10-12 2017-04-13 Gut Guide Oy Serotoniinivajeeseen liittyvän terveysriskin arvioiminen
PL2768312T3 (pl) 2011-10-18 2016-06-30 Nestec Sa Kompozycja do stosowania dla wspomagania zdrowego rozwoju oraz/albo w zapobieganiu oraz/albo w leczeniu chorób kości
TW201318566A (zh) * 2011-11-01 2013-05-16 Jimmy Lu 膳食補充劑組合物及其用於調控血糖之方法
WO2013130773A2 (fr) 2012-02-29 2013-09-06 Ethicon Endo-Surgery, Inc. Compositions de microbiota et leurs procédés associés
ITRM20120084A1 (it) 2012-03-07 2013-09-08 Aboca Spa Societa Agricola Miscela prebiotica.
WO2014007606A1 (fr) 2012-07-05 2014-01-09 N.V. Nutricia Produit pour l'utilisation dans le traitement prophylactique ou thérapeutique d'une émotion négative ou d'un comportement introverti
AU2013338774B2 (en) * 2012-11-01 2017-03-02 Academisch Ziekenhuis Groningen Methods and compositions for stimulating beneficial bacteria in the gastrointestinal tract
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
US20150296851A1 (en) * 2012-11-27 2015-10-22 Shanghai Jiao Tong University Compositions for Balancing Gut Microbiota and the Preparation and the Uses thereof
NZ711771A (en) 2013-02-04 2016-11-25 Seres Therapeutics Inc Compositions for treating or preventing or reducing the severity of clostridium difficile related diseases
US10973861B2 (en) 2013-02-04 2021-04-13 Seres Therapeutics, Inc. Compositions and methods
US10076546B2 (en) 2013-03-15 2018-09-18 Seres Therapeutics, Inc. Network-based microbial compositions and methods
CA2902248A1 (fr) * 2013-03-15 2014-09-25 Microbiome Therapeutics, Llc Fibre de cosse de soja activee
GB201312713D0 (en) * 2013-03-22 2013-08-28 Weaver Connie M Uses of soluble corn fibre for increasing colonic bacteria populations and increasing mineral absorption
GB201305708D0 (en) * 2013-03-28 2013-05-15 Clasado Inc Novel use
US20160051468A1 (en) * 2013-04-11 2016-02-25 Bright Drinks Inc. Compositions for Prevention and/or Treatment of Gastrointestinal Imbalances in Digestive Disorders
ITMI20131467A1 (it) * 2013-09-06 2015-03-07 Sofar Spa Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
KR102515850B1 (ko) 2013-11-25 2023-03-30 세레스 테라퓨틱스, 인코포레이티드 상승적 박테리아 조성물 및 그것의 생산 방법 및 용도
WO2015095241A2 (fr) 2013-12-16 2015-06-25 Seres Health, Inc. Compositions bactériennes et leurs méthodes d'utilisation pour traiter des troubles du système immunitaire
CN105828641A (zh) * 2013-12-20 2016-08-03 雀巢产品技术援助有限公司 用于减少肠病原体的营养组合物
MA39710A (fr) 2014-04-23 2015-10-29 Sofar Spa Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
CN104187624B (zh) * 2014-08-07 2016-06-08 逯明福 综合营养粉及其制备方法
WO2016029113A1 (fr) * 2014-08-22 2016-02-25 Abbott Laboratories Procédés d'augmentation de la production endogène de bêta-hydroxy-bêta-méthylbutyrate
MX2017003293A (es) 2014-09-30 2017-06-21 Kimberly Clark Co Composicion prebiotica sinergica.
WO2016053309A1 (fr) 2014-09-30 2016-04-07 Kimberly-Clark Worldwide, Inc. Tissu prébiotique crêpé
SG10201903823QA (en) 2014-10-31 2019-05-30 Whole Biome Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
CN104432069A (zh) * 2014-12-22 2015-03-25 威海百合生物技术股份有限公司 一种肠胃通畅片
JP6338113B2 (ja) * 2015-03-31 2018-06-06 株式会社東洋新薬 除脂肪体重の増加剤
EP3397960B1 (fr) * 2015-12-30 2020-01-29 Société des Produits Nestlé S.A. Méthode pour définir la masse du corps
EP3397074A1 (fr) * 2015-12-31 2018-11-07 Nestec S.A. Composition destinée à améliorer la sensation en bouche
AU2017216285B2 (en) * 2016-02-04 2023-10-05 Microbial Resource Management Health Nv Use of microbial communities for human and animal health
AU2017252409B2 (en) 2016-04-20 2023-08-24 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for nucleic acid expression and protein secretion in bacteroides
MA45327A (fr) 2016-05-13 2019-03-20 Sofar Spa Utilisation de probiotiques pour améliorer l'absorption des protéines
MA45288A (fr) 2016-06-08 2019-04-17 Sofar Spa Nouvelle utilisation médicale de probiotiques
US20180030403A1 (en) 2016-07-28 2018-02-01 Bobban Subhadra Devices, systems and methods for the production of humanized gut commensal microbiota
WO2018057914A1 (fr) * 2016-09-22 2018-03-29 The University Of Chicago Modulation de réaction immunitaire au moyen de produits biothérapeutiques vivants, dans des conditions telles que la désensibilisation allergique
IT201600122724A1 (it) 2016-12-02 2018-06-02 Sofar Spa Exopolysaccharides and uses thereof
AU2017376780A1 (en) 2016-12-15 2019-07-04 Novome Biotechnologies, Inc. Compositions and methods for modulating growth of a genetically modified gut bacterial cell
IT201600127498A1 (it) 2016-12-16 2018-06-16 Sofar Spa Probiotici per uso nella diverticolosi e malattia diverticolare
CN108245530A (zh) * 2016-12-28 2018-07-06 兰州奇正生态健康品有限公司 一种具有润肠通便作用的组合物及其制备方法与用途
ES2683014B1 (es) * 2017-03-23 2019-01-16 Cuetara S L Galleta infantil sin azúcares añadidos
WO2018237149A1 (fr) 2017-06-21 2018-12-27 Abbott Laboratories Procédés pour augmenter la croissance de bactéries bénéfiques dans le tractus gastro-intestinal
EP3668527A1 (fr) 2017-08-14 2020-06-24 Seres Therapeutics, Inc. Compositions et méthodes de traitement de la maladie cholestatique
EP3675882A4 (fr) 2017-08-30 2021-07-28 Pendulum Therapeutics, Inc. Methodes et compositions pour le traitement de troubles associés au microbiome
IT201700108039A1 (it) * 2017-09-27 2019-03-27 Neilos S R L Composizione per il trattamento della costipazione
IT201700108033A1 (it) * 2017-09-27 2019-03-27 Neilos S R L Composizione per il trattamento della costipazione
EP3466276A1 (fr) 2017-10-05 2019-04-10 Pharmactive Biotech Products, S.L. Composition de fibres diététiques pour protéger des composés bioactifs pendant le processus de digestion physiologique
AU2017438436B2 (en) * 2017-10-31 2022-01-13 Morinaga Milk Industry Co., Ltd. Muscle-building composition
CA3121707A1 (fr) * 2018-12-19 2020-06-25 Cosucra Groupe Warcoing S.A. Composition comprenant de la fibre de racine de chicoree et de paroi cellulaire de pois pour traiter des infections par brachyspira
EP3911179A2 (fr) 2019-01-18 2021-11-24 CP Kelco U.S., Inc. Composition prébiotique et son utilisation
WO2020161522A1 (fr) * 2019-02-06 2020-08-13 Thd S.P.A. Composition à base de fibres
FR3093427B1 (fr) * 2019-03-05 2021-03-05 Mativa Tech Composition pour son utilisation dans la prévention et/ou le traitement de la dysbiose
CN109820865A (zh) * 2019-04-09 2019-05-31 福州大学 低聚木糖和部分水解的瓜尔豆胶复配组合物在预防肥胖及保健品中的应用
JP7321503B2 (ja) * 2019-05-21 2023-08-07 フジ日本精糖株式会社 イヌリンを含む筋肉量減少抑制又は骨密度減少抑制剤
US20220248739A1 (en) 2019-05-29 2022-08-11 N.V. Nutricia Non-digestible oligosaccharides for decreased colonic protein fermentation
CN114377160A (zh) * 2019-07-09 2022-04-22 大连大学 一种落叶松阿拉伯半乳聚糖组合物的制备方法
EP3988664A4 (fr) * 2019-08-30 2023-06-21 Hem Pharma Inc. Procédé de criblage d'une substance personnalisée améliorant l'environnement intestinal à l'aide d'un procédé pmas
GB201915144D0 (en) * 2019-10-18 2019-12-04 Multigerm Uk Entpr Ltd Method of promoting SCFA production by gut microbiota
US11751597B2 (en) 2019-11-05 2023-09-12 Alfasigma S.P.A. Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
CN110679955A (zh) * 2019-11-11 2020-01-14 成都高新区九州华昀医疗美容门诊部有限公司 可改善肠道功能的大鲵活性肽营养组合物
CN115190765A (zh) * 2020-02-27 2022-10-14 雅培制药有限公司 改进骨健康的方法
CN111440841A (zh) * 2020-05-19 2020-07-24 爱礼康生物医药(苏州)有限公司 一种检测膳食纤维对人肠道菌活性影响的方法
WO2022083858A1 (fr) * 2020-10-21 2022-04-28 Compagnie Gervais Danone Gomme d'acacia pour une dysbiose microbienne induite par le fer
JP2022072243A (ja) * 2020-10-29 2022-05-17 帝人株式会社 腸内細菌叢改善用組成物及び腸内腐敗物質産生抑制用組成物
CN112715669A (zh) * 2020-11-24 2021-04-30 本溪木兰花乳业有限责任公司 一种改善便秘的牛奶制品及其制备方法
US20240058373A1 (en) 2020-12-09 2024-02-22 N.V. Nutricia Fibre mixture for young children
EP4119135A1 (fr) * 2021-07-13 2023-01-18 Luxia Scientific Methodes pour reequilibrer la flore intestinale chez les patients souffrant de la maladie de parkinson
WO2023288041A1 (fr) * 2021-07-16 2023-01-19 Purdue Research Foundation Composition prébiotique et procédé d'utilisation pour améliorer la santé gastro-intestinale de patients atteints de dysbiose et d'intestin perméable
CN113826892A (zh) * 2021-09-17 2021-12-24 潍坊易北特健康食品有限公司 一种基于肠道微生物调控特定胆汁酸的组合物及制备方法
JPWO2023054625A1 (fr) * 2021-09-29 2023-04-06
CN114224925A (zh) * 2021-12-23 2022-03-25 广东格物生物科技有限公司 一种调节肠道健康的益生菌组合物及其制备方法
ES2955633A1 (es) * 2022-04-26 2023-12-04 Servicio Andaluz De Salud Composición para la rehabilitación intestinal
CN115025116B (zh) * 2022-07-13 2023-11-21 纽湃腾(北京)医药科技有限公司 一种显著改善胃食管反流伴肠易激综合征的组合物及其应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5952314A (en) 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
DE69506095T2 (de) 1995-08-04 1999-06-24 Nutricia Nv Diätfasern enthaltende Nahrungszusammensetzung
ES2251755T3 (es) 1998-12-15 2006-05-01 Societe Des Produits Nestle S.A. Mezcla de fibras para composicion enteral.
CN1243551C (zh) * 2000-03-01 2006-03-01 雀巢制品公司 增强免疫反应的碳水化合物制剂(前生物佐剂)
EP1175905A1 (fr) * 2000-07-24 2002-01-30 Societe Des Produits Nestle S.A. Composition nutritive
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
EP1243273A1 (fr) 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition contenant un agent prebiotique pour le traitement d'inflammation et d'activation anormal des agents immunitaires non-spécifiques
GB0308104D0 (en) * 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
ITMI20040956A1 (it) * 2004-05-12 2004-08-12 Curti Alessandro Composizioni alimentari
EP1597978A1 (fr) 2004-05-17 2005-11-23 Nutricia N.V. Synergie de GOS et polyfructose
US8252769B2 (en) * 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
US9144250B2 (en) 2005-10-05 2015-09-29 Nestec S.A. Nutritional formulation for promoting catch-up growth
ITMI20062031A1 (it) * 2006-10-23 2008-04-24 Velleja Res Srl Composizioni per la prevenzione del depauperamento della flora intestinale e del danno d'organo successivi a terapia antibiotica
CN101534656B (zh) * 2006-11-07 2013-05-22 宝洁公司 包含纤维的组合物及其制备和使用方法
ITMI20071214A1 (it) 2007-06-15 2008-12-16 S I I T Srl Servizio Internazi Composizioni a base di componenti prebiotici ed immunogenici per la prevenzione e il trattamento di disturbi gastroenterici da disbiosi e/o alterazioni della normale flora intestinale
PL2178385T3 (pl) 2007-07-18 2012-12-31 Campina Nederland Holding Bv Termostabilny napój odżywczy i sposób jego wytwarzania
WO2009075564A1 (fr) 2007-12-10 2009-06-18 N.V. Nutricia Mélange de fibres pédiatriques
JP5992654B2 (ja) 2007-12-21 2016-09-14 ニュートリー株式会社 整腸及び/又は便通改善のための組成物
CN104206946A (zh) * 2009-11-12 2014-12-17 雀巢产品技术援助有限公司 用于促进肠微生物群平衡和健康的营养组合物

Also Published As

Publication number Publication date
DK2498626T3 (en) 2015-07-13
EP2498626A1 (fr) 2012-09-19
BR112012011294A2 (pt) 2015-09-15
US10015978B2 (en) 2018-07-10
HK1172516A1 (en) 2013-04-26
CN104206946A (zh) 2014-12-17
MX336032B (es) 2016-01-07
RU2012123959A (ru) 2013-12-20
MX2012004778A (es) 2012-06-01
BR112012011294B1 (pt) 2018-03-20
JP6006117B2 (ja) 2016-10-12
JP6205003B2 (ja) 2017-09-27
JP2013510865A (ja) 2013-03-28
WO2011060123A1 (fr) 2011-05-19
US20160100617A1 (en) 2016-04-14
US9192179B2 (en) 2015-11-24
CA2777941A1 (fr) 2011-05-19
CN102595934A (zh) 2012-07-18
ES2545597T3 (es) 2015-09-14
AU2010319490A1 (en) 2012-05-03
JP2016166176A (ja) 2016-09-15
EP2498626B1 (fr) 2015-06-17
AU2010319490B2 (en) 2015-03-19
US20120269865A1 (en) 2012-10-25
CA2777941C (fr) 2018-08-14

Similar Documents

Publication Publication Date Title
IN2012DN03632A (fr)
NZ602249A (en) Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders
CR20150097A (es) Composición inmunogénica
MX2012004869A (es) Formulaciones espesantes estables.
MX342423B (es) Metodos para usar inhibidores de cotransportadores 1 y 2 de glucosa y sodio.
WO2006110406A3 (fr) Compositions comprenant des composants probiotiques et des composants edulcorants
MX2010005424A (es) Proceso de recubrimiento particulado.
MX342107B (es) Composiciones de recubrimiento, composiciones de confiteria y goma de mascar y metodos.
TNSN07360A1 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
MX2012012837A (es) Composiciones farmaceuticas y metodos para su elaboracion.
MX2019012939A (es) Formulaciones que contienen linaclotida para administracion oral.
MX2015006971A (es) Composiciones alimenticias tipo barra.
UA96076C2 (en) Use of trans-clomiphene
NZ600094A (en) Method of enhancing muscle protein synthesis
MX2011012297A (es) Mejoramiento de la salud gastrointestinal, la inmunidad y el rendimiento mediante intervención dietética.
MX351037B (es) Composiciones de goma humectantes de la boca y productos que contienen las mismas.
NZ605147A (en) Compositions and methods containing alkylglycosides for stabilizing protein-containing formulations
HRP20231090T1 (hr) Pripravci i metode sinergističkog tretmana glikokaliksa
MX353099B (es) Metodo para producir particulas de polvo libre de poliamida impregnada con por lo menos un agente cosmetico o farmaceutico, y particulas de polvo libre de poliamida que tienen un contenido de por lo menos 25% en peso de por lo menos un agente cosmetico o farmaceutico diferente al agua.
MX2009005679A (es) Fluoresceina sustancialmente pura.
IN2011KN05169A (fr)
UA75461U (uk) Засіб для профілактики стоматологічних захворювань
MX2012002165A (es) Acidos grasos modificados con silicona, metodo de preparacion y su uso de los mismos.
SG194410A1 (en) Skin treatments containing carboxylic acid-substituted idebenone derivatives and methods of preparation and use thereof
UA97359C2 (en) Immunogenic composition